MN SF168 | 2023-2024 | 93rd Legislature

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on January 11 2023 - 25% progression, died in committee
Action: 2023-03-27 - Comm report: To pass as amended and re-refer to Judiciary and Public Safety
Pending: Senate Judiciary and Public Safety Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Excessive price increases by manufacturers prohibition to generic or off-patent drugs

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Excessive price increases by manufacturers prohibition to generic or off-patent drugs

Sponsors


History

DateChamberAction
2023-03-27SenateComm report: To pass as amended and re-refer to Judiciary and Public Safety
2023-03-20SenateComm report: To pass and re-referred to State and Local Government and Veterans
2023-03-15SenateWithdrawn and re-referred to Health and Human Services
2023-02-27SenateComm report: To pass as amended and re-refer to Judiciary and Public Safety
2023-02-06SenateAuthor added Hoffman
2023-01-27SenateAuthor added Fateh
2023-01-25SenateWithdrawn and re-referred to Commerce and Consumer Protection
2023-01-19SenateAuthor added Boldon
2023-01-11SenateReferred to Health and Human Services
2023-01-11SenateIntroduction and first reading

Same As/Similar To

HF17 (Similar To) 2023-02-08 - Committee report, to adopt as amended and re-refer to Health Finance and Policy

Minnesota State Sources


Bill Comments

feedback